⚠ RecallRadar📷 ScanGuidesOfficial U.S. recall notices, restated plainly

ASTRAZENECA PHARMACEUTICALS: Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distribute

DrugsSource: FDA (drug) · Date: 2025-10-22

Read the official notice at FDA (drug) →

Share on XFacebookRedditEmail

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.

Company / brand
ASTRAZENECA PHARMACEUTICALS
Product
Fasenra (benralizumab) Injection, 30 mg/mL, one single-dose pre-filled syringe, Rx only, Manufactured by: AstraZeneca AB, Sweden, Distributed by: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. NDC 0310-1730-30
Reason / hazard
Lack of Assurance of Sterility:
Classification
Class II
Status
Ongoing
Distribution / sold at
Nationwide in the U.S
Recall initiated
2025-10-08
Code info
Lot YJ0152, Expiry: 01/31/2028.
Product quantity
916 pre-filled syringes
Voluntary mandated
Voluntary: Firm initiated
City
Gaithersburg
State
MD
Country
United States
Event id
97760
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.